ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,553.51
1.06%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Surrozen Inc (SRZN) Quote

Surrozen Inc

Surrozen Inc (SRZN)

NASDAQ
10.00
-0.0999
(-0.99%)
Closed May 04 4:00PM
Delayed by 15 minutes
10.00
0.00
(0.00%)
After Hours: 5:16PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
10.00
Bid
9.55
Ask
11.65
Volume
736
9.85 Day's Range 10.10
4.50 52 Week Range 16.19
Market Cap
20.383M
Previous Close
10.0999
Open
10.10
Last Trade
2
@
9.61
Last Trade Time
Financial Volume
$ 7,405
VWAP
10.0608
Average Volume (3m)
17,710
Shares Outstanding
2,038,336
Dividend Yield
-
PE Ratio
-0.47
Earnings Per Share (EPS)
-21.12
Revenue
-
Net Profit
-43.04M

About Surrozen Inc

Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.surrozen.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Surrozen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SRZN. The last closing price for Surrozen was $10.10. Over the last year, Surrozen shares have traded in a share price range of $ 4.50 to $ 16.19.

Surrozen currently has 2,038,336 shares outstanding. The market capitalization of Surrozen is $20.38 million. Surrozen has a price to earnings ratio (PE ratio) of -0.47.

SRZN Latest News

More News

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis

In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved lung function Surrozen Wnt mimetic SWAP...

April 03 2024
GlobeNewswire Inc.

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043

-Phase 1a trial demonstrated acceptable safety and tolerability with no reported serious adverse events-Phase 1a data demonstrated target engagement, a pharmacodynamic effect and effects on liver...

April 01 2024
GlobeNewswire Inc.

Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules

-   $17.5 million upfront proceeds with up to an additional $175 million of proceeds upon the exercise of warrants-   Initial capital funds expansion of Phase 1b trial in severe alcohol-associated...

April 01 2024
GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]

February 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 07 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

January 22 2024
Edgar (US Regulatory)

Form 8-K - Current report

January 18 2024
Edgar (US Regulatory)

Surrozen Provides Corporate Update on Clinical Programs

Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043- Completed enrollment for the Phase 1a clinical trial in...

January 18 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

December 18 2023
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

December 13 2023
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.8622.85012285018.14118.14107379.91249341CS
4-0.86-7.9189686924510.8611.8258.141317710.21486163CS
120.818.813928182819.1916.198.141771011.21833057CS
263.476553.29194450836.523516.194.5403567.81322726CS
520.2052.092904543139.79516.194.5722718.55637022CS
156-133.25-93.0191972077143.252104.518049831.18025052CS
260-133.25-93.0191972077143.252104.518049831.18025052CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

SRZN Discussion

View Posts
Monksdream Monksdream 1 month ago
SRZN over $10
👍️0
csud1 csud1 1 year ago
What's up with all the 100 share buys?
👍️0
Joelzee Joelzee 1 year ago
Great day
👍️0
BEIJING BILL BEIJING BILL 1 year ago
Buying .60s
👍️0
81vette 81vette 1 year ago
sexy dilution lol>https://twitter.com/ThePberg/status/1602077645516472320/photo/1
👍️0
81vette 81vette 1 year ago
where?,post link,dilution lol,gapping/running 50% is dilution how?
👍️0
81vette 81vette 1 year ago
no shares to short=100s% win possible>0 2022-12-15 11:30:03,8.39% 0.00% 0 2022-12-15 11:15:03
8.39% 0.00% 0 2022-12-15 11:00:03
8.39% 0.00% 0 2022-12-15 10:45:03
8.39% 0.00% 0 2022-12-15 10:30:03
8.39% 0.00% 0 2022-12-15 10:15:04
8.39% 0.00% 0 2022-12-15 10:00:03
8.39% 0.00% 0 2022-12-15 09:45:04
8.39% 0.00% 0 2022-12-15 09:30:03
8.39% 0.00% 0 2022-12-15 09:15:04
8.39% 0.00% 0 2022-12-15 09:00:04
8.39% 0.00% 0 2022-12-15 08:45:03
8.39% 0.00% 0 2022-12-15 08:30:03
8.39% 0.00% 0 2022-12-15 08:15:03
8.39% 0.00% 0 2022-12-15 08:00:04
8.39% 0.00% 0 2022-12-14 17:45:04
8.39% 0.00% 0 2022-12-14 17:30:03
8.39% -4.57% 2000 2022-12-14 17:15:04
8.39% -4.57% 6000 2022-12-14 17:00:03
8.39% -4.57% 6000 2022-12-14 16:45:03
8.39% -4.57% 10000 2022-12-14 16:30:04
8.39% -4.57% 10000 2022-12-14 16:15:03
8.39% -4.57% 10000
👍️0
81vette 81vette 1 year ago
book value per share (mrq) $2.21
👍️0
willlbone willlbone 1 year ago
Dilution news
👍️0
81vette 81vette 1 year ago
no shares to short!!>Zero Borrow,Shares Outstanding 34.97M,Shares Float,32.70 institutional Ownership 70.10%,Insider Ownership 6.88%
👍️0
81vette 81vette 1 year ago
loaded .46 ,bounce babe,bounce!!!
👍️0
willlbone willlbone 1 year ago
Big volume today.
👍️0
l3gionFX l3gionFX 1 year ago
So, I guess I'll try making a post and seeing what comes of it.

Looks like the stock price is absolutely tanking on the bad news of pausing the clinical trials while invesitgating the liver stuff. I'm curious to know who's selling and buying right now. Obviously, it'll be too late to do anything, but I'm curious to see if there will be any of those insider trade filings or if any of the big investment funds adjusted their position.
👍️0

Your Recent History

NASDAQ
SRZN
Surrozen
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved